Free Trial

Forian (NASDAQ:FORA) Trading 2.6% Higher - Here's What Happened

Forian logo with Medical background

Key Points

  • Forian Inc. shares rose by 2.6% during mid-day trading, reaching a high of $2.39 before closing at $2.37.
  • The trading volume increased by 73% compared to the average session volume, with 44,780 shares changing hands.
  • Forian specializes in data management and analytical solutions aimed at optimizing operational, clinical, and financial performance in the healthcare sector.
  • MarketBeat previews the top five stocks to own by October 1st.

Forian Inc. (NASDAQ:FORA - Get Free Report) shares traded up 2.6% during mid-day trading on Monday . The stock traded as high as $2.39 and last traded at $2.37. 44,780 shares changed hands during trading, an increase of 73% from the average session volume of 25,829 shares. The stock had previously closed at $2.31.

Forian Stock Up 2.6%

The company has a 50 day moving average of $2.02 and a 200-day moving average of $2.03. The stock has a market capitalization of $73.74 million, a P/E ratio of -26.33 and a beta of 1.00.

Forian Company Profile

(Get Free Report)

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Forian Right Now?

Before you consider Forian, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.

While Forian currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.